BOSTON, June 11, 2018 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc.
Read moreParatek Presents New Analysis from Combined Phase 3 Skin Infection Studies Highlighting Efficacy of Omadacycline in Treating Drug Resistant S. aureus
Home »
AMA: docs declare drug shortages public health emergency
(HealthDay)—At the annual meeting of the American Medical Association (AMA),
Read moreHow can patients be protected from post-surgery opioid addiction?
Greater coordination is needed between surgeons and physicians about the
Read moreWhite House launches anti-opioid ad campaign aimed at youth
The White House launched a series of new advertisements Thursday
Read moreDiscovery opens door for synthetic opioids with less addictive qualities
Making opioids from sugar instead of from field grown opium
Read moreUS doctors prescribing fewer opioid painkillers: report
US doctors reduced the number of prescriptions for opioid painkillers
Read moreNew treatment approved for rare disease PKU
(HealthDay)—Palynziq (pegvaliase-pqpz) has been approved by the U.S. Food and
Read moreResearchers publish study on new therapy to treat opioid use disorder
Better delivery of medications to treat opioid use disorder (OUD)
Read moreNew study sheds light on the opioid epidemic and challenges prevailing views about this public health crisis
A study published in the American Journal of Preventive Medicine
Read moreDoptelet approved for liver disease patients slated for a medical procedure
(HealthDay)—Doptelet (avatrombopag) has been approved by the U.S. Food and
Read more